AB
Amalgamated Bank Portfolio holdings
AUM
$13B
1-Year Return
23.92%
This Quarter Return
+0.49%
1 Year Return
+23.92%
3 Year Return
+105.94%
5 Year Return
+196.1%
10 Year Return
+496.3%
AUM
$11.8B
AUM Growth
-$631M
(-5.1%)
Cap. Flow
-$549M
Cap. Flow
% of AUM
-4.63%
Top 10 Holdings %
Top 10 Hldgs %
19.95%
Holding
2,211
New
30
Increased
190
Reduced
1,935
Closed
47
Top Buys
| 1 |
Moderna
MRNA
|
$21M |
| 2 |
Match Group
MTCH
|
$6.82M |
| 3 |
Analog Devices
ADI
|
$6.38M |
| 4 |
GXO Logistics
GXO
|
$5.97M |
| 5 |
Janus Henderson
JHG
|
$5.65M |
Top Sells
| 1 |
Microsoft
MSFT
|
$22.5M |
| 2 |
Apple
AAPL
|
$22.3M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$11.6M |
| 4 |
Amazon
AMZN
|
$10.9M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$9.56M |
Sector Composition
| 1 | Technology | 21.62% |
| 2 | Financials | 14.52% |
| 3 | Healthcare | 13.01% |
| 4 | Consumer Discretionary | 12.03% |
| 5 | Industrials | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IVC
2101
DELISTED
Invacare Corporation
IVC
| $79K | ﹤0.01% |
16,694
-217
| -1% | -$1.03K |
|
2102
MRC Global
MRC
$1.28B
| $78K | ﹤0.01% |
10,634
-674
| -6% | -$4.94K |
|
2103
Theravance Biopharma
TBPH
$718M
| $78K | ﹤0.01% |
+10,559
| New | +$78K |
|
2104
Karyopharm Therapeutics
KPTI
$60.4M
| $76K | ﹤0.01% |
871
-35
| -4% | -$3.05K |
|
|
CMRX
2105
DELISTED
Chimerix, Inc.
CMRX
| $76K | ﹤0.01% |
12,277
-515
| -4% | -$3.19K |
|
|
PAE
2106
DELISTED
PAE Incorporated Class A Common Stock
PAE
| $75K | ﹤0.01% |
12,597
-515
| -4% | -$3.07K |
|
2107
Akebia Therapeutics
AKBA
$785M
| $72K | ﹤0.01% |
25,033
-732
| -3% | -$2.11K |
|
2108
Kopin
KOPN
$339M
| $72K | ﹤0.01% |
14,078
-578
| -4% | -$2.96K |
|
2109
Standard BioTools
LAB
$497M
| $70K | ﹤0.01% |
10,560
-315
| -3% | -$2.09K |
|
2110
Catalyst Pharmaceutical
CPRX
$2.45B
| $69K | ﹤0.01% |
13,045
-593
| -4% | -$3.14K |
|
2111
Alaunos Therapeutics
TCRT
$4.15M
| $69K | ﹤0.01% |
254
-10
| -4% | -$2.72K |
|
2112
Expro
XPRO
$1.44B
| $69K | ﹤0.01% |
3,917
-169
| -4% | -$2.98K |
|
|
VIEW
2113
DELISTED
View, Inc. Class A Common Stock
VIEW
| $69K | ﹤0.01% |
213
+15
| +8% | +$4.86K |
|
2114
Accuray
ARAY
$170M
| $66K | ﹤0.01% |
16,782
-687
| -4% | -$2.7K |
|
2115
TETRA Technologies
TTI
$625M
| $65K | ﹤0.01% |
20,944
-875
| -4% | -$2.72K |
|
|
ASXC
2116
DELISTED
Asensus Surgical, Inc.
ASXC
| $65K | ﹤0.01% |
34,971
-1,429
| -4% | -$2.66K |
|
|
BDSI
2117
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $61K | ﹤0.01% |
16,896
-692
| -4% | -$2.5K |
|
|
AMPE
2118
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $59K | ﹤0.01% |
118
-2
| -2% | -$1K |
|
2119
CytomX Therapeutics
CTMX
$348M
| $58K | ﹤0.01% |
11,386
-396
| -3% | -$2.02K |
|
|
SIEN
2120
DELISTED
Sientra, Inc.
SIEN
| $58K | ﹤0.01% |
1,008
-42
| -4% | -$2.42K |
|
|
AUD
2121
DELISTED
Audacy, Inc.
AUD
| $58K | ﹤0.01% |
15,884
-720
| -4% | -$2.63K |
|
2122
Geron
GERN
$887M
| $56K | ﹤0.01% |
40,600
-1,841
| -4% | -$2.54K |
|
2123
MEI Pharma
MEIP
$135M
| $54K | ﹤0.01% |
983
-41
| -4% | -$2.25K |
|
2124
TrueCar
TRUE
$189M
| $54K | ﹤0.01% |
13,061
-761
| -6% | -$3.15K |
|
2125
Atossa Therapeutics
ATOS
$101M
| $53K | ﹤0.01% |
16,113
-714
| -4% | -$2.35K |
|